The existence of numerous neuropeptides in milk, in concentrations that exceed those in maternal plasma, is well established. It is still unclear whether these neuropeptides are produced by the mammary gland or that the gland concentrates them from the general circulation. In this study, we have examined the possibility that the genes of these neuropeptides are expressed in the rat mammary gland. RNA was extracted from the mammary glands of female rats during different stages of reproduction as well as from other tissues such as hypothalami, pancreas, pineal glands, small intestine, and ovaries. Following RT reaction, the resulting cDNA were amplified by radioactive PCR using specific oligonucleotide primers. We have used specific primers for the following neuropeptides: galanin, somatostatin, vasoactive intestinal peptide, TRH, GH-releasing hormone, cholecystokinin, neurotensin, oxytocin, and relaxin. We have also used primers for serotonin N-acetyl-transferase, the enzyme that is involved in melatonin biosynthesis. The ribosomal protein S-16 served as an internal control. Among all the neuropeptides that have been examined, somatostatin was the only one that was found to be expressed in the mammary gland. Somatostatin was expressed in the mammary gland of lactating rats, but not of virgin rats. Expression of the somatostatin gene was confirmed by Southern blot analysis and by sequencing of the PCR products. Immunohistochemical studies demonstrated somatostatin immunoreactivity in the epithelial cells that compose the secretory alveoli and in the secretory material. In addition, we have found that the mammary glands of the lactating rat express the PC-1 proteinase gene that process prosomatostatin to generate somatostatin-14, but do not express furin, the enzyme that is responsible for somatostatin-28 production. This finding substantiates previous studies that demonstrated that only somatostatin-14 is present in milk. The finding that most of the neuropeptides, examined by RT-PCR, are not expressed by the mammary gland suggest that these neuropeptides are actively concentrated by the mammary glands from the general circulation. The GnRH gene has been previously demonstrated to be expressed in the mammary gland, and in this study somatostatin was the only neuropeptide that was found to be produced by the mammary gland. The observation that only a small portion of the neuropeptides that are present in milk are being produced by the lactating mammary gland suggest that these neuropepetides have important functions in the biology of the suckling neonate and probably also in the development and function of the breast. (Endocrinology 140: [5915][5916][5917][5918][5919][5920][5921] 1999) T HE PRESENCE of neuropeptides in the milk of several species, in concentrations that exceed those in maternal plasma, has been reported. GnRH and TRH were initially identified in milk (1), and since then numerous other neuropeptides such as oxytocin (2), neurotensin (3), vasoactive intestinal peptide (VIP) (4), somatostatin (SOM)-14 (5, 6), GH-releasing hormone (GHRH) (6, 7), cholecystokinin (CCK) (8), and melatonin (9) have been found to be present in milk of several species. For reviews, see Refs. 10 -13. These findings imply that milk is not just a nutrient source but also a carrier of substances that can play a role in the developmental physiology of the neonate.
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The high concentration of neuropeptides in milk can be a result of a transport mechanism that concentrate the neuropeptides from the general circulation of the lactating mother or by gene expression in the mammary gland (MG) tissue itself. Recently our group have demonstrated the expression of the GnRH gene in the MG of pregnant and lactating rats (14) .
In this study, we have used radioactive RT-PCR and Southern blot hybridization procedures to study the possible expression of several neuropeptides in the MG of rats at different physiological states. We have found that only SOM, in addition to GnRH, is expressed in the MG of the lactating rat.
Materials and Methods Animals
Three-to four-month-old Wistar-derived female rats were maintained under controlled environmental conditions (air conditioned quarters, ambient temperature of 22 C, illumination between 0500 and 1900 h, relative humidity 45-55%). Food and water were offered ad libitum.
RNA preparation
The hypothalami, pancreas, pineal glands, small intestine, and ovaries served as control tissues and were obtained from virgin rats. The mammary glands were collected from virgin rats, pregnant rats (6th and 19th days), lactating rats (10 and 21 days) and postlactating (1 and 2 weeks) rats. The rats were decapitated and the relevant tissues were immediately excised and RNA was extracted. Total RNA was extracted using Trizol RNA isolation reagent (Molecular Research Center, Inc., Cincinnati, OH) based on the acid guanidinium thiocyanatephenol-chloroform extraction method, according to manufacturer's recommendations.
Radioactive RT-PCR analysis
The radioactive RT-PCR procedure was performed as described by Orly et al. (15) . The indicated amounts of total RNA (100 -1000 ng) were reverse transcribed for 75 min at 42 C using 500 ng polydeoxythymidine [(pd (T)] 12-18 primers (no. 27-7858, Pharmacia & Upjohn, Piscataway, NJ), and 0.25 U AMV reverse transcriptase (no. M510, Promega Corp., Madison, WI) in a 20 l reaction containing 1 ϫ PCR buffer (no. M190, Promega Corp., containing: 50 mm KCl; 10 mm Tris-HCl, pH 9; and 0.1% Triton X-100), 4 mm MgCl 2 , 1 mm deoxy-NTPs (no. R0181 MBI Fermentas, Vilnius, Lithuania) and 20 U RNAguard ribonuclease inhibitor (Pharmacia & Upjohn no. 27-0815). The RT reaction was terminated by heating for 5 min at 95 C, and 10 l 1 ϫ PCR buffer containing the following reagents were added to the same tube: 500 ng of the appropriate oligonucleotide primers (50 -60 pmol), 2 Ci [␣-
32 P] deoxy-CTP (3000 Ci/mmol), 2.5 U Taq DNA polymerase (no. M186A, Promega Corp.), as well as 500 ng oligonucleotide primers for the ribosomal protein S-16 as an internal control. The internal control was examined separately when the reaction conditions did not allow four primers at the same reaction. The volume was brought to 100 l by the addition of 70 l 1 ϫ PCR buffer containing 2.5 mm MgCl 2 . PCR was performed for 20 -35 cycles (Mastercycler 5330, Eppendorf, Hamburg, Germany) using a denaturing temperature of 94 C (30 sec), an annealing temperature of 58Ϫ62 C (30 sec), and extension temperature of 72 C (1 min). Twenty microliters from the PCR products were analyzed by electrophoresis on 5% polyacrylamide gels in 0.5 ϫ Tris-borate-EDTA buffer. The gels were dried under vacuum and heated (1 h; 60 C), and the various amplified PCR bands were quantified using a phosphorimager (445 SI, Molecular Dynamics, Inc., Jersey City, NJ). The radioactivity in each of the PCR bands was normalized to the radioactivity of the S-16 band as an internal control. Gels were also exposed to x-ray film (Fuji Photo Film Co., Ltd., Tokyo, Japan) for 2-16 h at Ϫ80 C and developed in CURIX 60 processor (AGFA, Germany).
Southern analysis
The PCR products were transferred to a nylon membrane (Nytran 0.45, Schleicher & Schuell, Inc., Dassel, Germany) in 20 ϫ SSC solution overnight. The nylon was baked in a vacuum oven at 80 C for 2 h. Prehybridization was performed in the presence of 6 ϫ SSC, 5 ϫ Denhardt's solution, 5 mm EDTA and 0.2 mg/ml Salmon sperm DNA for 3 h at 60 C. Overnight hybridization was performed in the presence of a 32 P-labeled probe, specific to the somatostatin cDNA. The corresponding band can be seen after 1 h of exposure using a phosphorimager.
Oligonucleotide primers
We used the following specific SOM oligonucleotide primers: 5Ј GC-CGCGCTCTGCATCGTCCTG 3Ј and 5Ј CAGCTCCAGCCT-CATCTCGTC 3Ј corresponding to nucleotides 131-151 (sense) and 959 -979 (antisense), respectively (16) . The predicted size of band is 228 bp. The oligonucleotide probe for hybridization was 5Ј CAGTTCTGCCAA-GAAGTACTT 3Ј, corresponding to nucleotides 869 -889. For internal control, we used primers to the ribosomal protein S-16 as described by Foley et al. (17) . The other sets of primers that were used in this study are presented in Table 1 .
DNA sequencing
Nucleotide sequencing of the specific PCR bands were achieved by automated direct DNA sequencing, according to manufacturer's recommendations (PE Applied Biosystems; model 377, Perkin-Elmer Corp., Foster City, CA).
Tissue preparation for immunocytochemistry
Mammary tissue was collected from 10 days lactating rats and 5 days lactating mice. Small pieces (Ͻ5 mm 3 ) were fixed immediately in 10% buffered formalin for 12 h at room temperature, and washed once in 70% ethanol. The tissues were then processed for paraplast embedding and sectioning. Sections (4 m) were mounted on glass slides, deparaffinized, and rehydrated before immunostaining.
Immunocytochemical staining
The sections were pretreated with 0.3% hydrogen peroxide for 15 min to reduce endogenous peroxidase activity. Following three washes with PBS (0.1 m), the sections were incubated for 2 h in a blocking medium (PBS containing 10% normal goat serum, 2% BSA, 1% glycin, 0.5% Triton X-100) to saturate nonspecific binding sites for IgG. The sections were incubated with antisera to somatostatin (1:2000) (6) or with nonimmune rabbit serum (overnight at 4 C), rinsed well, and incubated with biotinylated goat antirabbit IgG (1:200 dilution) for 90 min followed by avidin-biotin-horseradish peroxidase complex (ABC Vectastain, Vector Laboratories, Inc., Burlingame, CA) for an additional 90 min. After each step the sections were rinsed three times in PBS (0.1 m). The antibodyperoxidase complex was reacted with a mixture containing diaminobenzidine (DAB, 0.5 mg/ml) and 0.01% hydrogen peroxide. The sections were then rinsed and mounted with Permount (Entellan, Merck, Darmstadt, Germany). To determine the specificity of the signals we preabsorbed aliquots of the antibody with excess (10 -100 g) of SOM-14 for 24 h. Parallel sections were stained with hematoxylin to demonstrate the morphological structure of the tissues.
Results
The radioactive PCR products derived from MG, hypothalami, pancreas, pineal glands, ovaries, and small intestine were quantified by a phosphorimager and normalized according to the radioactivity of the S-16, control bands. The RT-PCR products for the neuropeptides GHRH (Fig. 1A) , galanin (Fig. 1B), neurotensin (Fig. 1C), relaxin (Fig. 1D) , as well as CCK, VIP, oxytocin, TRH, and the enzyme N-acetyltransferase (NAT) (data not shown) were present only in the respective control tissues (hypothalami, ovaries or pineal glands) but not in the MG at any of its developmental stages. The expression of the internal control, the ribosomal protein S-16, was demonstrated in all the tissues that were examined (Fig. 1) .
The design of the primers was carried out by using the Oligo 4 program. When possible, different exons for the sense and antisense primers were chosen to avoid false positive results, caused by DNA contamination (Fig. 2A) . Somatostatin was the only neuropeptide that was expressed in the lactating MG In the initial studies (500 ng of total RNA and 35 cycles of PCR), we found that the low levels of SOM that were expressed at the late stages of pregnancy were increased during lactation, declined at the end of the lactation period and further declined one week after weaning (Fig. 2B) . Quantitative RT-PCR assays were carried out in the linear phase of amplification (Fig. 3A) as described by Hannon et al. (29) . Amplified SOM fragments were calibrated by using MG tissues that were obtained from rats on the 10th day of lactation (500 ng of total RNA and 32 cycles of PCR). When this protocol was performed (Fig. 3B) , a SOM fragment was observed in preparations of MG tissues that were obtained from rats only during the intense lactation period. Indeed, it has been demonstrated that during early involution of the MG, at the late stages of lactation, the MG has reverted to the pattern of messenger RNA (mRNA) metabolism that is characteristic to the stage of late pregnancy (30) . The RT-PCR products derived from hypothalami, pancreas, and mammary glands of virgin, pregnant, and lactating rats were also hybridized with a rat SOM 32 P synthetic oligonucleotide probe. The predicted 228-bp band was detected in the hypothalami, pancreas, and MG of lactating, but not in the MG of virgin or pregnant rats (Fig. 3C) .
The amplified product obtained from the MG of 10-day lactating rats was eluted from the agarose gel, and the nucleotide sequence was determined. This sequence was identical ( Fig. 3D) to that of the hypothalamic SOM cDNA sequence (nucleotides 131-238 (exon 1) and 860 -979 (exon 2)) (16) .
The posttranslational processing of prosomatostatin by the serine proteinases furin and PC-1 is known to generate the two forms of SOM, SOM-28 and SOM-14, respectively (31). Because SOM-14, but not SOM-28, is found in milk (5, 6), we have studied the expression of the two enzymes in the rat MG The immunocytochemical localization of SOM in the rats and mice mammary gland shows intense staining for SOM throughout the epithelial cells cytoplasm (Fig. 5B) , and in the secretory material (Fig. 5C) . No immunoreactivity was observed using antibody preabsorbed with excess of SOM-14, or nonimmune serum, emphasizing the specificity of the signals.
Discussion
The presence of numerous neuropeptides in mammalian milk and our recent finding that GnRH is expressed by the pregnant and lactating MG raises the question concerning the origin of the other neuropeptides that are present in milk. By using molecular biology techniques, we examined the expression of seven neuropeptides (GHRH, oxytocin, TRH, neurotensin, CCK, VIP, and SOM) that are known to be present in the milk of several species (2-7, 10 -13). In addition, we have examined the expression of galanin, a neuropeptide that is known to be colocalized with GnRH in the preoptic hypothalamic neurons (32, 33) , and of relaxin that plays a major role in MG biology (23, 34) . The expression of melatonin in the MG was studied by measuring the expression of serotonin NAT, a key enzyme in the biosynthesis of melatonin (26) .
Our studies have demonstrated that, apart from SOM (Figs. 2 and 3) , all other neuropeptides are not expressed in the MG (Fig. 1) . The inability of previous studies to demonstrate the presence of mRNA for SOM (35) is probably due control (without RNA). C, Southern blot hybridization of amplified SOM cDNA fragments: Amplified SOM cDNA fragments from hypothalamus, MG, and pancreas of rats were hybridized to a rat SOM 32 P-labeled oligonucleotide probe. Lanes: 1, MG from virgin rats; 2, MG from 6 day pregnant rats; 3, MG from 19 day pregnant rats; 4, MG from 10 day lactating rats; 5, hypothalamus; 6, pancreas; 7, negative control (without cDNA). D, The nucleotide sequence of the amplified lactating MG SOM cDNA. The 228-bp product is identical to nucleotides 131-238 (exon 1) and 860 -979 (exon 2) of hypothalamic SOM (17) . The location of the primers used in the RT-PCR reaction are underlined. FIG. 3 . A, Quantitative RT-PCR assay of SOM and S-16 transcripts obtained from ten days lactating MG Using 500 ng of the total RNA, PCR was performed for increasing numbers of amplification cycles, and the radioactive bands were quantified by a phosphorimager. B, 32 P-labeled RT-PCR analysis: amplified SOM and S-16 cDNA fragments from hypothalamus and MG of rats. Lanes: 1, MG from virgin rats; 2, MG from pregnant rats (19th day); 3, MG from 10th day lactating rats; 4, MG from 21st day lactating rats (day of weaning); 5, MG from 2 weeks postweaning rats; 6, hypothalamus; 7, negative to the use of low sensitivity detection methodologies. For positive control, we have studied the expression of GHRH, oxytocin, TRH, CCK, VIP, SOM, galanin, and neurotensin in the hypothalamus. All these peptides were found to be expressed in the hypothalamus. It is important to note that Strbak et al. (36) has previously examined the expression of TRH in the MG and concluded that it is not originated from local synthesis in the MG. Of special interest is relaxin, which is known for its important functions in the MG, and which has been shown to be expressed in the MG of the guinea pig (37) . In our studies, relaxin mRNA could not be detected in the rat MG, either by hybridization of the PCR cDNA products with a 32 P-labeled relaxin probe (data not shown) or by radioactive RT-PCR analysis (Fig. 1D) . In contrast, clear evidence for the existence of relaxin mRNA were obtained in rat ovarian samples (Fig. 1D, lane 6) . Similarly, no relaxin mRNA could be found in the rabbit MG (38) , and no relaxin immunostaining could be observed in the rat MG (39) . Thus, taken together, these results suggest that there are species differences in the expression of relaxin in the MG and that relaxin is expressed in the MG of the guinea pigs, only.
Somatostatin is probably the most widely distributed neuropeptide. Neurons containing SOM are redundant in the hypothalamus and the limbic system, whereas smaller amounts were found in the brain stem, spinal cord, and throughout the cerebral cortex (40) . SOM is secreted from different parts of the gastrointestinal tract and from ␦ cells of the endocrine pancreas (41) . SOM was first discovered in human and sheep milk (5). We and others have found that SOM levels in milk are severalfold higher than those present in maternal plasma (5, 42, 43) . It is established that SOM-28 is the predominant form of the neurohormone in plasma (5, 44) , whereas milk contains SOM-14 but not SOM-28 (5, 6, 42) . Therefore, the relative concentration of SOM-14 in milk is even higher than that calculated by comparing the ratio of total SOM concentration in milk vs. plasma.
The mammalian SOM precursor, prosomatostatin, is a 92-amino acid protein that is processed posttranslationally by proteinases to produce SOM-14 and SOM-28. The production of the two somatostatins is independent of each other, and SOM-14 cannot be processed from SOM-28 (31) . We have found (Fig. 4) that PC-1, the protease that produces SOM-14, is indeed expressed in the MG tissue of the lactating rat, whereas the furin, which is responsible for the processing of SOM-28, is not. These finding are compatible with previous findings (5, 6, 42) that have reported the existence of SOM-14, but not of SOM-28, in milk. The absence of SOM-28 in milk also support the notion that the active transport of biological substances into milk is a selective process, and therefore not every substance that occur in the general circulation is collected by the MG Rao et al. (45) have demonstrated that rat milk protects SOM from degradation in the intestinal lumen of the suckling rat. The SOM degrading activity in suckling pups was found to be significantly lower than in weaning pups (46) . SOM was also found to be more stable in the duodenal lumen of suckling than of adult rat, and milk-peptidase inhibitor apparently enhanced that stability (47) . In previous studies, we have determined that about 95% of the ]-SOM that remained in the stomach, 1 h after its oral administration to 10-day-old suckling animals, had retained its original chromatographic behavior. In contrast, most of the radioactivity that was recovered from plasma could be attributed to degradation products (35) . These results indicate that SOM remains largely intact in the stomach of the suckling rat and can be absorbed from the gastrointestinal tract in a biologically active form.
The present findings demonstrate that SOM is produced by the MG tissue only during a restricted period of time, during lactation. The regulation of SOM gene expression in the MG, as well as the biological activities of SOM that is synthesized by the MG, are still unknown. SOM may exert its bioactivity on the suckling pups as well as on the MG itself. Evidence for a possible physiological role for SOM and GnRH were presented recently by Gama and Alvares (48) , who reported that GnRH and SOM have exerted inhibitory effects on cell proliferation of the gastric epithelium in suckling rats. The fact that SOM and GnRH are expressed in the MG of lactating rats may imply that regulatory peptides produced by the breast can play a major role in the developmental physiology of the neonate and/or on the growth and differentiation of the MG itself. Furthermore, the fact that only two, GnRH and SOM, out of ten neuropeptides that have been studied so far, are expressed in the MG of the lactating rat, imply that the production of neuropeptides by the MG is selective and suggests that these neuropeptides may have important physiological roles that have still to be elucidated. These results also imply that most of the peptides that are present in milk are actively concentrated from the general circulation.
Somatostatin, like GnRH, is also synthesized by the human placenta (49, 50) . Thus the placenta and the breast seem to serve as complementary organs by which the mother exercises control over the development and the metabolism of the embryo and the suckling infant. The presence of numerous neuropeptides in milk suggests that milk is not just a nutrient but that it provides a channel to transfer biological information from the mother to the infant.
